Candidemia in French hospitals: incidence rates and characteristics

Pfaller, 1998, National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program, Diagn Microbiol Infect Dis, 31, 327, 10.1016/S0732-8893(97)00240-X Karlowsky, 1997, Candidemia in a Canadian tertiary care hospital from 1976 to 1996, Diagn Microbiol Infect Dis, 29, 5, 10.1016/S0732-8893(97)00068-0 Banerjee, 1991, Secular trends in nosocomial primary blood stream infections in the United States 1980–89. National Nosocomial Infections Surveillance System, Am J Med, 3B, 86S, 10.1016/0002-9343(91)90349-3 Jarvis, 1995, Epidemiology of nosocomial fungal infections, with emphasis on Candida species, Clin Infect Dis, 20, 1526, 10.1093/clinids/20.6.1526 Wey, 1988, Hospital-acquired candidemia: The attributable mortality and excess length of stay, Arch Intern Med, 148, 2642, 10.1001/archinte.1988.00380120094019 Debusk, 1994, Candidemia: Current epidemiologic characteristics and a long-term follow-up of the survivors, Scand J Infect Dis, 26, 697, 10.3109/00365549409008638 Bregenzer, 1996, Clinical aspects and prognosis of candidemia, a 6-year retrospective study, Schweiz Med Wochenschr, 126, 1829 Fraser, 1992, Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality, Clin Infect Dis, 15, 414, 10.1093/clind/15.3.414 Voss, 1996, Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch University Hospitals, Eur J Clin Microbiol Infect Dis, 15, 909, 10.1007/BF01690507 Voss, 1997, Candidemia in intensive care unit patients: risk factors for mortality, Infection, 25, 8, 10.1007/BF02113499 Girmenia, 1998, Fluconazole and the changing epidemiology of candidemia, Clin Infect Dis, 27, 232, 10.1086/517694 Pfaller, 1998, J Clin Microbiol, 36, 1886, 10.1128/JCM.36.7.1886-1889.1998 Pfaller, 2000, Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America 1997–98, Antimicrob Agents Chemother, 44, 747, 10.1128/AAC.44.3.747-751.2000 Nguyen, 1996, The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance, Am J Med, 100, 617, 10.1016/S0002-9343(95)00010-0 Colombo, 1999, High rate of non albicans candidemia in Brazilian tertiary care hospitals, Diagnostic Microbiol Infect Dis, 34, 281, 10.1016/S0732-8893(99)00042-5 Martino, 1996, Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: Clinical aspects, predisposing factors and differential pathogenicity of the causative strains, Clin Infect Dis, 23, 506, 10.1093/clinids/23.3.506 Levy, 1998, Emergence of Candida parapsilosis as the predominant species causing candidemia in children, Clin Infect Dis, 26, 1086, 10.1086/520277 Wenzel, 1995, Nosocomial candidemia: Risk factors and attributable mortality, Clin Infect Dis, 20, 1531, 10.1093/clinids/20.6.1531 Viscoli, 1999, Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group of the European Organization of Research and Treatment of Cancer (EORTC), Clin Infect Dis, 28, 1071, 10.1086/514731 Yamamura, 1999, Canadian sites: Results from the Fungal Disease Registry. 1992–94. Fungal Disease Registry of the Canadian Infectious Disease Society, CMAJ, 160, 493